The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: Preliminary results

International Urogynecology Journal

Volumn 19, Issue 7, 2008, Pages 987-990

  Daha, Lukas K ^a,b   Lazar, Dara ^a,b   Simak, Reiner ^a,b   Pflüger, Heinz ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b HIETZING HOSPITAL   (Austria)

Author keywords

Bladder; Interstitial cystitis; Pain; Pentosanpolysulfate

Indexed keywords

ANTIBIOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYALURONIC ACID; PENTOSAN POLYSULFATE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTALGIA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; MAINTENANCE THERAPY; OPEN STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT DURATION; VISUAL ANALOG SCALE;

EID: 44649134513     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-008-0560-8     Document Type: Article

References (16)

1. Hanno PM (2005) Painful bladder syndrome/interstitial cystitis and related disorders. In: Patrick C, Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ (eds) Campbell's urology. 8th edn. Saunders, Philadelphia, p 631
2. Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732-735
3. Parsons CL, Housley T, Schmidt JD, Lebow D (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73:504-507
4. Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ (1997) A placebo controlled study of intravesical pentosanpolysulfate for the treatment of interstitial cystitis. Br J Urol 79:168-171
5. Steinhoff G, Ittah B, Rowan S (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 9:1454-1458
6. Riedl CR, Daha LK, Pflüger H, Hohlbrugger G (2004) Intravesical hyaluronic acid for the treatment of interstitial cystitis: An update. Eur Urol Suppl 3, Nr. 2: A LB15
7. Morales A, Emerson L, Nickel JC, Lundie M (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:145
8. Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26-29
9. Holm-Bentzen M, Jacobsen F, Nerstrøm B, Lose G, Kristensen JK, Pedersen RH, Krarup T, Feggetter J, Bates P, Barnard R, Larsen S, Hals T (1987) A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 138:503-507
10. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR (1990) Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology 35:552-558
11. Karsenty G, AlTaweel W, Hajebrahimi S, Corcos J (2006) Efficacy of interstitial cystitis treatment: A review. EAU-EBU Update Series 4:47-61
12. Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on interstitial cystitis. National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140:203-206
13. O'Leary MP, Sant GR, Fowler FJ, Whitmore KE, Spolarich-Kroll J (1997) The interstitial cystitis symptom index and problem index. Urology 49[5A Suppl]:58-63
14. Kallestrup EB, Steinunn S, Jørgensen S, Nordling J, Hald T (2005) Treatment of interstitial cystitis with Cystistat®: A hyaluronic acid product. Scand J Urol Nephrol 39:143-147
15. Stein PC, Torri A, Parsons LC (1999) Elevated urinary norepinephrine in interstitial cystitis. Urology 53:1140-1143
16. Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC (2000) Pentodanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: An alternative explanation of its beneficial effect in interstitial cystitis. J Urol 164:2119-2125